By Rich Haridy August 25, 2022 The new treatment is hoped to be available within the next 12 months Depositphotos Research published in The New England Journal of Medicine has reported positive Phase 3 trial results for a new monoclonal antibody treatment targeting rheumatoid arthritis. The novel therapy is hoped to offer a new option for patients...
